Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Large Decrease in Short Interest

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) was the recipient of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 2,400 shares, a decline of 95.8% from the November 30th total of 56,900 shares. Based on an average trading volume of 1,090,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.1% of the company’s stock are sold short.

Shuttle Pharmaceuticals Price Performance

SHPH stock traded up $0.01 during midday trading on Thursday, reaching $0.78. 55,118 shares of the company’s stock traded hands, compared to its average volume of 429,963. The firm has a 50-day moving average price of $1.03. The stock has a market capitalization of $2.87 million, a price-to-earnings ratio of -0.19 and a beta of -1.70. Shuttle Pharmaceuticals has a 52 week low of $0.58 and a 52 week high of $4.95.

About Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .